Prostate Cancer

• CLINICAL_TRIALS trial_result · 2020-11-25
  Clinical Trial Update: Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy [Phase 2]

  Phase 2 trial update for enzastaurin in prostate cancer patients who have undergone hormonal therapy and chemotherapy has completed with res…

• CLINICAL_TRIALS trial_result · 2020-11-24
  Clinical Trial Update: Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer [Phase 1, Phase 2]

  Clinical trial update for stereoTactic Ablative Adaptive Radiotherapy treatments in localized prostate cancer (Phase 1/Phase 2).

• CLINICAL_TRIALS trial_result · 2020-11-24
  Clinical Trial Update: A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer [Phase 2]

  Phase 2 study of Aplidin (Plitidepsin) in advanced prostate cancer was terminated, with results posted in 2020.

• CLINICAL_TRIALS trial_result · 2020-11-24
  Clinical Trial Update: SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN) [Phase 1, Phase 2]

  A clinical trial update for SABR including regional lymph node irradiation in high-risk prostate cancer across Phase 1 and Phase 2.

• CLINICAL_TRIALS trial_result · 2020-11-24
  Clinical Trial Update: Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer [Phase 1, Phase 2]

  Clinical trial update describing safety and efficacy of hypofractionated radiotherapy combined with androgen deprivation therapy for prostat…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-11-23
  Clinical Trial Update: uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness [Phase 2]

  Phase 2 clinical trial evaluating uPAR-PET/MRI for assessing tumor aggressiveness in prostate cancer.

• CLINICAL_TRIALS trial_result · 2020-11-19
  Clinical Trial Update: Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation [Phase 3]

  Phase 3 trial update on zoledronate for preventing bone loss in men with prostate cancer on long-term androgen deprivation; study terminated…

• CLINICAL_TRIALS trial_result · 2020-11-19
  Clinical Trial Update: 11C- and 18F-Choline PET/MR Imaging for Prostate Cancer [Phase 2]

  Phase 2 clinical trial evaluating 11C- and 18F-Choline PET/MR imaging in prostate cancer has completed with results posted.

• CLINICAL_TRIALS trial_result · 2020-11-17
  Clinical Trial Update: Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy [Phase 3]

  Phase 3 trial comparing Rhenium-188-HEDP to Radium-223-chloride in advanced prostate cancer with bone metastases; results not yet available.

• CLINICAL_TRIALS trial_result · 2020-11-17
  Clinical Trial Update: 68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa) [Phase 1, Phase 2]

  Clinical trial updates for 68Ga-PSMA-R2 in biochemical relapse and metastatic prostate cancer completed Phase 1 and Phase 2 with posted resu…

• CLINICAL_TRIALS trial_result · 2020-11-16
  Clinical Trial Update: Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer. [Phase 2]

  Phase 2 trial update evaluating abiraterone acetate with docetaxel after progression to abiraterone in metastatic castration-resistant prost…

• CLINICAL_TRIALS trial_result · 2020-11-06
  Clinical Trial Update: A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients [Phase 2]

  Phase 2 study evaluating enzastaurin in combination with chemotherapy versus placebo with chemotherapy for prostate cancer has completed wit…

• CLINICAL_TRIALS trial_result · 2020-11-02
  Clinical Trial Update: Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer [Phase 2]

  A Phase 2 clinical trial using multiparametric MRI to evaluate intraprostatic tumor responses and androgen resistance patterns in newly diag…

• CLINICAL_TRIALS trial_result · 2020-10-23
  Clinical Trial Update: [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) [Phase 2]

  Phase 2 imaging trial evaluating [68Ga]-NeoBOMB1 for GRPR-expressing tumors has terminated; results posted.

• CLINICAL_TRIALS trial_result · 2020-10-22
  Clinical Trial Update: Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer [Phase 3]

  Phase 3 trial update evaluating hormone therapy plus chemotherapy in treating prostate cancer has completed.

• CLINICAL_TRIALS trial_result · 2020-10-22
  Clinical Trial Update: Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer [Phase 3]

  A Phase 3 trial comparing adjuvant radiation therapy plus hormone therapy versus radiation therapy alone in stage II/III prostate cancer has…

• CLINICAL_TRIALS trial_result · 2020-10-22
  Clinical Trial Update: Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer [NA]

  A completed feasibility trial evaluating image-guided external beam radiotherapy with optional high-dose-rate brachytherapy boost for interm…

• CLINICAL_TRIALS trial_result · 2020-10-22
  Clinical Trial Update: Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

  Phase 1 dose-finding study of GSK2636771 in combination with enzalutamide in metastatic castration-resistant prostate cancer completed.

• CLINICAL_TRIALS trial_result · 2020-10-22
  Clinical Trial Update: External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer [Phase 2]

  Phase 2 trial evaluating external-beam radiation therapy plus implanted radiation therapy for prostate cancer has completed.

• CLINICAL_TRIALS trial_result · 2020-10-14
  Clinical Trial Update: PSMA Imaging of Localized Prostate Cancer [Phase 2]

  Phase 2 clinical trial update on PSMA imaging for localized prostate cancer; results posted after completion.

• CLINICAL_TRIALS trial_result · 2020-10-14
  Clinical Trial Update: Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery [Phase 2]

  Phase 2 trial evaluating Gallium-68 PSMA-11 PET/CT and Fluorine-18 Fluciclovine PET/CT imaging in men with recurrent prostate cancer after s…

• CLINICAL_TRIALS trial_result · 2020-10-12
  Clinical Trial Update: Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer [Phase 2]

  Phase 2 trial evaluating enzalutamide in combination with hormone therapy before, during, and after radiation in high-risk localized prostat…

• CLINICAL_TRIALS trial_result · 2020-10-01
  Clinical Trial Update: A Pilot Study of the Feasibility of Chronic Cavernous Nerve Stimulation to Promote Regeneration and Erectile Function [NA]

  A pilot study assessing feasibility of chronic cavernous nerve stimulation to promote regeneration and erectile function in prostate cancer …

• CLINICAL_TRIALS trial_result · 2020-09-25
  Clinical Trial Update: Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients [Phase 2]

  Phase 2 study investigating neoadjuvant PEMbrolizumab before radical prostatectomy in high-risk prostate cancer patients is reported as an u…

• CLINICAL_TRIALS trial_result · 2020-09-23
  Clinical Trial Update: Stereotactic Body Radiotherapy for Prostate Cancer [NA]

  Clinical trial update reporting completed status for stereotactic body radiotherapy in prostate cancer with results posted.